MARK4 inhibitor 4 is a MARK4 inhibitor with an IC50 of 1.49 μM. MARK4 inhibitor 4 can be used in cancer and tau lesion-related research.
MARK4 inhibitor 4 (Compound 23c) (1-20 μM; 24 h) has obvious inhibitory effect on the growth of Hela and U87MG cells, with EC50s value of 2.16 and 3.51 μM, respectively[1].
References:
[1]. Voura M, et al. Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors[J]. ACS Pharmacology & Translational Science, 2023.
















